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Trends in clinical indicators of care for adult peritoneal dialysis Medicare’s end-stage renal disease (ESRD) program
patients in the United States from 1995 to 1997. celebrated its 25th year in September 1998 and remains
Background. This article describes the changes in four core the only nationally funded disease-specific program inindicator variables: dialysis adequacy, hematocrit, serum albu-
the United States, providing payment for life-sustainingmin, and blood pressure in peritoneal dialysis CAPD and cycler
renal replacement therapies to more than 250,000 bene-patients over a three-year period.
Methods. A national random sample of adult peritoneal dial- ficiaries [1]. The Health Care Financing Administration
ysis patients in the United States was drawn each study period. (HCFA), the federal agency that operates the Medicare
Clinical data abstraction forms were completed by facility staff ESRD program, is responsible to the public for prudentlyfor patients selected for the sample, returned to the respective
managing the resources it administers and for ensuringnetwork, then forwarded to the Health Care Financing Admin-
that acceptable quality of care is delivered to Medicareistration for analysis.
Results. The mean weekly Kt/V urea for CAPD patients beneficiaries. However, until 1994, there was no system
increased from 1.91 in 1995 to 2.12 in 1997 (P , 0.001) and in place that described the quality indicators of care
for cycler patients, from 2.12 in 1996 to 2.24 in 1997 (P , 0.05).
provided to the hemodialysis and peritoneal dialysisThe mean weekly creatinine clearance for CAPD patients in-
(PD) patient populations.creased from 61.48 liter/week/1.73 m2 in 1995 to 65.84 liter/
week/1.73 m2 in 1997 (P , 0.05). For cycler patients, it increased In response to the need to assess and improve care
from 63.37 liter/week/1.73 m2 in 1996 to 67.45 liter/week/1.73 for all Medicare beneficiaries, the HCFA initiated the
m2 in 1997 (P , 0.05). Despite this increase in adequacy values, Health Care Quality Improvement Program (HCQIP) as
less than 40% of peritoneal dialysis patients in 1997 had weekly
a strategy to stimulate health care providers to improveKt/V urea or creatinine clearance values that met subsequently
measurably the care of Medicare beneficiaries [2]. Thepublished National Kidney Foundation’s Dialysis Outcomes
Quality Initiative (DOQI) guidelines. These data suggest that HCQIP focuses on improving the outcomes of care by
the dialysis prescription may not be adequately modified to providing comparative information and technical sup-
compensate for increased body weight and for decreased resid- port to assist health care professionals in improving care.ual renal function as years on dialysis increase. The average
The HCQIP model assumes that most health care pro-hematocrit value increased modestly in both CAPD and cycler
viders need and welcome both information and, wherepatients from 1995 to 1997, and the number of patients with
a hematocrit of less than 25% decreased from 6% in 1995 to necessary, help in applying the tools and techniques of
1.4% in 1997 (P , 0.001). Both serum albumin values and quality management [3]. The HCQIP model moves away
systolic and diastolic blood pressure values were essentially
from the quality assurance model to the continuous qual-unchanged during the three-year period of observation.
ity improvement (CQI) model. This new strategy wasConclusions. Despite improvements in dialysis adequacy
and hematocrit values, there remains much room for improve- implemented by HCFA through its contractors: the Peer
ment in these core indicator values. Review Organizations in 1992 and the ESRD Network
Organizations in 1994 (Fig. 1).
In 1994, the ESRD Core Indicators Project (CIP) wasKey words: CAPD, cycler dialysis, dialysis adequacy, end-stage renal
disease, Kt/V urea, creatinine clearance, NKF-DOQI guidelines. implemented by HCFA through the ESRD network or-
ganizations as a HCQIP initiative to assist renal profes-Received for publication July 16, 1998
sionals to improve care and outcomes of dialysis patientsand in revised form December 18, 1998
Accepted for publication December 21, 1998 by establishing a mechanism for the collection, analysis,
and distribution of population-based comparative clini- 1999 by the International Society of Nephrology
1998
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Fig. 1. End-stage renal disease (ESRD)
network regions in the United States.
cal information. The ESRD CIP design resulted from 46% of the patients had a hematocrit level of more than
30% [5].collaborative efforts between HCFA, the ESRD net-
As a result of the success of the first-year data collec-works, health care professionals, and dialysis providers
tion to describe the care received by hemodialysis patients,in response to concerns regarding the quality of care
the ESRD Core Indicators Workgroup recommendedprovided to Medicare ESRD beneficiaries in the areas
to HCFA that the clinical measures be collected on adultof adequacy of dialysis, treatment of anemia, and mortal-
PD patients. PD is the predominant form of home dial-ity risk [4]. An ESRD Core Indicators Workgroup, com-
ysis in the United States and is used by approximatelyposed of representatives from the ESRD networks, renal
15% of all U.S. patients receiving renal replacementcommunity, and HCFA, was established to provide guid-
therapy [6]. A PD subcommittee of the Core Indicatorsance to HCFA in the administration of the project.
Workgroup was formed, and an annual retrospectiveThe ESRD CIP systematically collects clinical infor-
data collection on a national sample of these patientsmation on a national sample of ESRD patients to de-
commenced in the summer of 1995. This report describesscribe important clinical measures for these patients at
the ESRD CIP findings for the adult (18 years or more)a point in time. The collection of clinical data is then
PD patients from 1995 to 1997.repeated annually to describe changes and/or improve-
ments in the clinical measures over time. The results
from the ESRD CIP are used by dialysis providers to METHODS
benchmark their performance, to establish target ranges, Study design and sample selection
and to identify opportunities for improving their health A random sample of Medicare-eligible adult PD pa-
care processes to improve patient outcomes. tients (referred to hereafter as adult PD patients) was
The first year of the ESRD CIP (summer 1994) was selected from an end-of-year ESRD patient census for
limited to the collection of clinical data on a national 1994, 1995, and 1996. Patients were eligible for inclusion
sample, stratified by network area, of adult (18 years or in the sample if (a) the patient was at least 18 years old
more) in-center hemodialysis patients to pilot test the as of October 1 of the study period and (b) the patient
collection and feedback mechanism of the project. Pro- was receiving PD and alive on December 31 of the study
viders overwhelmingly participated in the data collection period. The sample size was determined to produce a
effort (response rate of 97%), and HCFA was able to 95% level of confidence with a 65% accuracy interval
produce a feedback report describing the adult hemodi- for the national estimates. All 18 network areas were
alysis population within six months after the collection included each study year. A medical chart review was
of the data. The findings from this first-year retrospective conducted to establish estimates of patterns of care. Clin-
data collection found that at the end of 1993, only 43% ical information was obtained on the selected patients
of the adult in-center hemodialysis patients received dial- for three different two-month time periods each study
period: November through December, January throughysis at a urea reduction ratio of 65% or more, and only
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February, and March through April. For example, for prescription information the first study year, we catego-
rized patients as either CAPD or cycler patients thatthe most recent data collection, referred to as the 1997
study period, clinical information was abstracted from year based on the response to the instruction “Check
the patient’s modality for each two-month time period.”the medical records for the time periods November
through December 1996, January through February In subsequent study years, the patient’s modality was
categorized based on specific prescription information1997, and March through April 1997.
on the data collection form.
Data collection The calculation of weekly Kt/V urea and creatinine
clearance values was performed by standard methods,The ESRD networks sent a two-page data collection
form to the dialysis treatment facility for each patient in using data from 24-hour dialysate and urine collections.
For Kt/V urea, residual renal function was calculatedthe sample. Patient information available from network
databases included gender, age, race (Caucasian, African using urine urea clearance only. For creatinine clearance,
residual renal function was calculated to be the averageAmerican, Asian/Pacific Islander, American Indian/
Alaska Native, and other/unknown), and the primary of the urine urea and creatinine clearances. The total
body water (V) was determined by the method of Wat-diagnosis associated with ESRD (diabetes mellitus, hy-
pertension, glomerulonephritis, and other/unknown). son et al [7], and body surface area (BSA) was calculated
using the formula by DuBois and DuBois [8].This information was printed on the data collection form
and was independently verified by dialysis facility staff. Comparisons were made between the results of values
from 1994 to 1996 and National Kidney Foundation’sClinical data, abstracted from medical records by treat-
ment center staff for each two-month period, included Dialysis Outcomes Quality Initiative (DOQI) Guide-
lines that were developed and distributed in 1997. Thepatient height and weight, modality, the first documented
data points in each two-month time period required to authors do not intend to imply that guidelines were ig-
nored in 1994 to 1996 because these guidelines were notcalculate adequacy measurements (including 24-hour di-
alysate and urine collections for urea, creatinine, and established until 1997. In our analyses, the following cut
volume), reported weekly Kt/V urea and weekly creati- points were used to compare with DOQI guidelines: for
nine clearance values, dialysis prescription information weekly Kt/V urea, 2.0, 2.1, and 2.2 for CAPD patients,
at the time of the adequacy measurement, the first docu- cycler patients with a daytime dwell, and cycler patients
mented value in each two-month time period for hemato- without a daytime dwell, respectively; and for weekly
crit, transferrin saturation, ferritin concentration, upright creatinine clearance, 60, 63, and 66 liter/week/1.73 m2
blood pressure measurements, serum albumin, the labo- for CAPD patients, cycler patients with a daytime dwell,
ratory method used [bromcresol green (BCG) or brom- and cycler patients without a daytime dwell, respectively.
cresol purple (BCP)], and the most recent four-hour Data analyses were performed using Epi Info, version
creatinine dialysate-to-plasma ratio from the peritoneal 6.04 [9] and SPSS for Windows version 6.1 [10]. Analyti-
equilibration test (PET). Information on iron prescrip- cal methods included the calculation of descriptive pa-
tion and epoetin alfa dosing (at the time immediately rameters, including percentiles for distributions in which
before the documented hematocrit was drawn) was also the mean and median values differed. Comparative test-
collected for each two-month time period. ing used the two-tailed Student t-test assuming equal
variances, hierarchical analysis of variance, and chi-
Consistency of data abstraction square analyses. A two-tailed P value of less than 0.05
The consistency of data submitted by the treatment was considered significant.
centers was assessed in a separate data abstraction con-
sistency study. For this study, ESRD network staff reab-
RESULTSstracted data from a 5% random sample of patient charts
The response rate for completed data collection formspreviously abstracted by facility staff. No significant dif-
from facilities that had one or more patients in theseferences in data collected were found between charts
national samples was 91% (1202 out of 1328) in 1995,abstracted by facility personnel and network staff.
92% (1208 out of 1317) in 1996, and 89% (1219 out
Data analysis of 1375) in 1997. Selected patient characteristics of the
samples are described in Table 1. The samples had higherResults were stratified for presentation by gender, age
percentages of Caucasians and younger patients com-group (18 to 44 years, 45 to 64 years, and 651 years),
pared with adult, in-center hemodialysis patient samplesrace (Caucasian, African American, and other/unknown),
[11]. The proportion of cycler patients increased duringand reported primary diagnosis of the cause of ESRD
this study period from 25% in 1995 to 43% in 1997.(diabetes mellitus, hypertension, glomerulonephritis,
Approximately 60% of the cycler patients had a daytimeand other/unknown). We conducted separate analyses
on CAPD and cycler patients. As we did not collect dwell in both 1996 and 1997.
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Table 1. Characteristics of adult ($18 years) peritoneal patients in the ESRD Core Indicators Project, 1995–1997
1995 1996 1997
CAPD Cycler patients CAPD Cycler patientsa CAPD Cycler patientsb
N (%) N (%) N (%) N (%) N (%) N (%)
Total 951 (100) 306 (100) 796 (100) 402 (100) 757 (100) 521 (100)
Gender
Males 499 (52) 177 (58) 425 (54) 229 (57) 378 (50) 279 (54)
Females 452 (48) 129 (42) 368 (46) 172 (43) 379 (50) 242 (46)
Race
African American 244 (26) 74 (24) 211 (26) 94 (23) 201 (27) 116 (22)
Caucasian 646 (68) 208 (68) 507 (64) 267 (66) 477 (63) 357 (69)
Other/unknown 61 (6) 24 (8) 78 (10) 41 (10) 79 (10) 48 (9)
Age group years
18–44 264 (28) 95 (31) 216 (27) 112 (28) 192 (25) 140 (27)
45–64 383 (40) 120 (39) 335 (42) 170 (42) 362 (48) 228 (44)
651 304 (32) 91 (30) 245 (31) 120 (30) 203 (27) 153 (29)
Primary diagnosis
Diabetes mellitus 281 (33) 80 (29) 278 (35) 134 (33) 260 (34) 179 (34)
Hypertension 216 (25) 68 (25) 176 (22) 88 (22) 166 (22) 114 (22)
Glomerulonephritis 192 (22) 71 (26) 144 (18) 80 (20) 142 (19) 89 (17)
Other/unknown 174 (20) 56 (20) 196 (25) 100 (25) 189 (25) 139 (27)
Percentages may not add up to 100% due to rounding.
a 244/402 (61%) of cyclers had a daytime dwell in the 1995 study period
b 322/521 (62%) of cyclers had a daytime dwell in the 1996 study period
Fig. 2. Percentage of adult peritoneal dialysis
patients with calculated and reported weekly
adequacy measures during the six-month study
period from 1995 to 1997, ESRD Core Indica-
tors Project. Symbols are: (h) 1995; ( ) 1996;
( ) 1997. Significant differences 1995–1997 for
calculated measures and 1996–1997 for reported
measures: P , 0.001.
Adequacy measures ined between the group with adequate data and the
group with insufficient data to calculate an adequacyData returned by respondents were sufficient to allow
measure. Figure 2 depicts the improvement in the per-the calculation of weekly Kt/V urea values for 48% of
centage of patients with reported and calculated ade-patients in 1995, for 58% in 1996, and for 64% in 1997.
quacy measures during the study period. Despite thisWeekly creatinine clearance values could be calculated
improvement, in 1997, more than 25% of patients didfor 41% of patients in 1995, 56% in 1996, and 64% in 1997.
not have at least one adequacy measure recorded forIn 1995, there were significantly fewer African Ameri-
the six-month period of observation.can patients (CAPD only, P , 0.001) and patients with
Mean calculated weekly Kt/V urea and creatininehypertension (both CAPD and cycler patients, P , 0.05)
clearance values for the CAPD and cycler cohorts areas a primary cause of ESRD in the group of patients
shown in Tables 2 and 3. Median clearance values werewith adequate data to calculate an adequacy measure
uniformly lower than mean clearance values. The meancompared with the group with insufficient data to calcu-
weekly Kt/V urea and creatinine clearance values, as welllate an adequacy measure. In 1996 and 1997, there were
no significant differences by patient characteristics exam- as the percentage of patients with calculated adequacy
Frankenfield et al: Trends in PD indicators2002
Table 2. Mean calculated weekly Kt/V urea values and the percent of patients who received dialysis meeting subsequently published DOQI
guidelinesa, by gender, race, age group, primary diagnosis, years on dialysis, quartile BSA, and modality, 1995–1997;
ESRD Core Indicators Project
1996 1997
1995 CAPD CAPD Cycler patients CAPD Cycler patients
% meeting % meeting % meeting % meeting % meeting
Mean DOQI Mean DOQI Mean DOQI Mean DOQI Mean DOQI
Total 1.91 23 2.00 27 2.12 28 2.12 36 2.24 36
Median 1.90 1.90 2.00 2.00 2.20
Gender
Males 1.76d 15 1.84d 19 1.92d 20 1.94d 26 2.08d 27
Females 2.06 31 2.20 36 2.38 39 2.30 46 2.42 47
Race
African American 1.70b 14 1.98 24 2.04 26 2.04 30 2.16 31
Caucasian 1.97 26 2.00 26 2.14 28 2.16 40 2.25 38
Other/unknown 1.80 27 2.06 38 2.12 31 2.04 30 2.26 39
Age group years
18–44 1.94 23 1.88b 20 2.05 27 2.09 33 2.27 36
45–64 1.81 20 2.05 28 2.19 28 2.14 35 2.24 37
651 1.99 26 2.04 31 2.08 29 2.10 41 2.20 37
Primary diagnosis
Diabetes mellitus 1.97 25 2.00 23 2.17 30 2.14 37 2.30 38
Hypertension 1.84 22 2.07 30 2.13 36 2.07 35 2.21 38
Glomerulonephritis 1.79 17 1.87 25 2.04 20 2.11 31 2.25 32
Other/unknown 2.00 28 2.02 31 2.10 24 2.13 40 2.17 34
Years on dialysis
,1 2.06d 28 2.13d 34 2.21b 30 2.25c 43 2.31 41
1–2 1.94 25 1.98 26 2.17 31 2.06 33 2.26 35
21 1.71 17 1.87 20 1.98 23 2.02 32 2.15 32
Quartile BSA m2
Low–25th percentile 2.11d 40 2.23d 48 2.33d 41 2.37d 58 2.53d 55
25th–50th percentile 1.99 29 2.10 32 2.20 32 2.10 42 2.21 36
50th–75th percentile 1.82 20 1.84 24 2.12 31 2.04 40 2.19 47
75th percentile–High 1.63 16 1.82 20 1.86 19 1.96 31 2.03 29
a DOQI guidelines:
For CAPD patients: Kt/V urea $ 2.0
For cycler patients with daytime dwell: Kt/V urea $ 2.1
For nighttime cycler patients (no daytime dwell): Kt/V urea $ 2.2
Statistically significant differences between patient characteristic group means denoted by: b P , 0.05; c P , 0.01; d P , 0.001
measures that would have met subsequently published DOQI guidelines [12] for CAPD and cycler patients (Figs.
3 and 4, respectively). The mean weekly Kt/V urea valueDOQI Clinical Practice Guidelines for Peritoneal Dial-
ysis Adequacy (guideline numbers 15 and 16) [12], varied for CAPD patients increased from 1.91 in 1995 to 2.12 in
1997 (P , 0.001). For cycler patients, it increased fromby patient characteristics. Although not uniformly statis-
tically significant across the three-year study period and 2.12 in 1996 to 2.24 in 1997 (P , 0.05; Table 2). The mean
weekly creatinine clearance value for CAPD patients in-modality, males and African Americans experienced
lower weekly adequacy measures compared with other creased from 61.48 liter/week/1.73 m2 in 1995 to 65.84
liter/week/1.73 m2 in 1997 (P , 0.05). For cyclers, itgroups. Patients with a duration of dialysis greater than
two years were more likely to have calculated weekly increased from 63.37 liter/week/1.73 m2 in 1996 to 67.45
liter/week/1.73 m2 in 1997 (P , 0.05; Table 3).creatinine clearance values that would not have met sub-
sequently published DOQI guidelines compared with The correlation coefficients between the reported and
calculated adequacy values were 0.75 and 0.85 for weeklypatients with a shorter duration of dialysis therapy (P ,
0.001). Patients with a body surface area (BSA) greater Kt/V urea and 0.69 and 0.78 for weekly creatinine clear-
ances in the study years of 1996 and 1997, respectively.than the 75th percentile (approximately 1.98 m2) were
more likely to have calculated weekly Kt/V values that The differences in the facility-reported versus our calcu-
lated values were at least partially because of the variouswould not have met subsequently published DOQI ade-
quacy guidelines than patients with lower BSA (P , methods used by facilities to calculate these adequacy
values. Dialysis facilities reported that for Kt/V urea,0.001).
There has been improvement from 1995 to 1997 in the they calculated the volume using the Watson equation
in approximately 12% and the Hume equation in approx-percentage of patients with weekly Kt/V urea and cre-
atinine clearance values that met subsequently published imately 11% of patients. For creatinine clearance, their
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Table 3. Mean calculated weekly creatinine clearance values (liter/week/1.73 m2) and the percent of patients who received dialysis meeting
subsequently published DOQI guidelinesa, by gender, race, age group, primary diagnosis, years on dialysis, quartile BSA, and modality,
1995–1997; ESRD Core Indicators Project
1996 1997
1995 CAPD CAPD Cycler patients CAPD Cycler patients
% meeting % meeting % meeting % meeting % meeting
Mean DOQI Mean DOQI Mean DOQI Mean DOQI Mean DOQI
Total 61.48 21 64.35 30 63.37 26 65.84 34 67.45 33
Median 57.25 59.60 59.05 60.70 62.25
Gender
Males 59.58 20 64.78 33 63.04 28 65.37 32 70.52c 38
Females 63.56 23 63.52 26 63.82 25 66.30 35 63.74 26
Race
African American 55.14b 14 62.91 26 59.19 20 63.66 33 63.96 27
Caucasian 63.83 24 65.10 31 64.73 27 66.75 34 68.72 35
Other/unknown 55.21 22 64.50 38 59.44 28 65.61 33 62.88 26
Age group years
18–44 62.32 20 59.38c 24 60.86 23 66.14 34 70.28 36
45–64 60.10 21 67.59 32 65.37 28 66.23 33 66.36 33
651 62.56 23 64.32 32 62.87 28 64.86 35 66.51 29
Primary diagnosis
Diabetes mellitus 64.76 26 66.70b 31 69.13b 33 68.62 37 71.14 36
Hypertension 59.88 18 68.36 32 61.76 27 61.74 28 65.48 25
Glomerulonephritis 57.45 17 60.98 28 60.18 22 66.04 31 63.30 36
Other/unknown 63.23 23 60.36 29 58.14 20 65.63 36 67.50 32
Years on dialysis
,1 71.77d 31 72.44d 39 71.52d 34 73.87d 44 74.98d 43
1–2 58.27 22 65.68 33 62.51 34 62.79 29 67.92 33
21 51.72 11 56.22 20 53.94 13 60.16 27 59.57 22
Quartile BSA m2
25th percentile–Low 61.16 27 66.36 39 62.79 25 70.03b 47 70.03 37
25th–50th percentile 66.38 28 64.10 33 63.81 27 61.94 30 63.12 32
50th–75th percentile 59.42 23 61.63 32 63.93 31 67.44 47 69.60 47
75th percentile–High 59.10 22 65.26 36 62.87 33 63.98 35 66.69 34
a DOQI guidelines:
For CAPD patients: creatinine clearance $ 60 liter/week/1.73 m2
For cycler patients with daytime dwell: creatinine clearance $ 63 liter/week/17.3 m2
For nighttime cycler patients (no daytime dwell): creatinine clearance $ 66 liter/week/1.73 m2
Statistically significant differences between patient characteristic group means denoted by: b P , 0.05; c P , 0.01; d P , 0.001
Fig. 3. Improvement in weekly Kt/V urea and weekly creatinine clear-
ance values for CAPD patients from 1995 to 1997. ESRD Core Indica- Fig. 4. Improvement in weekly Kt/V urea and weekly creatinine clear-
tors Project. Symbols are: (h) 1995; ( ) 1996; ( ) 1997. Significant ance values for PD cycler patients from 1995 to 1997. ESRD Core
differences from 1995 through 1997 for both adequacy measures is P , Indicators Project. Symbols are: ( ) 1996; ( ) 1997. Significant differ-
0.001. ence 1996–1997 for Kt/V urea: P , 0.01; significant difference 1996–1997
for creatinine clearance: P , 0.05.
quacy, subdivided by duration of dialysis and BSA, arereported adequacy values were not corrected for BSA
in approximately 66 and 57% of patients in 1996 and shown in Table 4. For the 1996 sample, 29% of the
subgroup of patients with calculated adequacy values1997, respectively.
The peritoneal and renal components of dialysis ade- were anuric, and 9% did not have a renal component
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Table 4. Peritoneal and renal components of the weekly calculated Kt/V urea and creatinine clearance values, by BSA (m2) quartile and
duration of dialysis (in years), 1996–1997; ESRD Core Indicators Project
Weekly calculated Kt/V urea Weekly calculated creatinine clearance (liter/week/1.73 m2)
Peritoneal component Renal component Peritoneal component Renal component
Quartile BSA (m2) ,1 year 1–2 years 21 years ,1 year 1–2 years 21 years ,1 year 1–2 years 21 years ,1 year 1–2 years 21 years
1996
Low–25th percentile 1.97 1.88 1.93 0.38 0.38 0.17 54.81 49.41 53.85 25.93 19.12 9.62
25th–50th percentile 1.73 1.77 1.81 0.49 0.28 0.09 49.18 44.65 47.28 24.85 13.32 5.39
50th–75th percentile 1.53 1.60 1.76 0.53 0.25 0.12 44.02 46.41 49.31 27.76 14.07 6.04
75th percentile–High 1.32 1.47 1.53 0.44 0.39 0.11 41.16 41.79 46.22 28.71 21.46 6.41
1997
Low–25th percentile 1.98 2.03 2.14 0.54 0.38 0.17 51.02 52.75 54.20 28.31 22.04 8.37
25th–50th percentile 1.80 1.82 1.96 0.40 0.32 0.14 46.42 46.56 51.59 22.56 16.00 6.60
50th–75th percentile 1.63 1.88 1.83 0.53 0.24 0.10 45.34 49.58 54.65 28.10 13.61 6.38
75th percentile–High 1.52 1.58 1.69 0.52 0.26 0.14 42.64 46.44 49.04 28.99 16.32 7.69
For 1996, 29% of this subset were anuric and 9% had no renal component reported; for 1997, 30% of this subset was anuric and 10% had no renal component
reported.
Table 5. Calculated dialysis adequacy values, body weight in kg, body surface area, prescribed volume, and most recent four-hour
PET test result for D/P creatinine from 1995 to 1997; ESRD Core Indicators Project
1995 1996 1997
CAPD Cycler patients CAPD Cycler patients CAPD Cycler patients
Weekly
Mean Kt/V urea 1.91 (60.85) 2.22 (61.1) 2.0 (60.60) 2.12 (60.64) 2.12 (60.64) 2.24 (60.56)
Median Kt/V urea 1.90 2.00 1.90 2.00 2.00 2.20
Weekly
Mean CCr 61.48 (631.6) 59.95 (632.5) 64.35 (623.6) 63.37 (623.5) 65.84 (624.7) 67.45 (624.4)
Median CCr 57.25 53.70 59.60 59.05 60.70 62.25
Mean wt kg 74.63 (618.1) 76.67 (619.7) 75.72 (619.9) 76.76 (620.9) 76.65 (618.7) 75.86 (619.3)
Median wt kg 73.0 74.0 73.0 74.25 76.0 75.0
Mean BSA m2 1.83 (60.23) 1.87 (60.26) 1.83 (60.28) 1.84 (60.28) 1.85 (60.25) 1.84 (60.25)
Median BSA m2 1.80 1.90 1.80 1.85 1.85 1.80
Mean prescribed
volume ml xxxx xxxx 8552 (61878) 11770 (63676) 8976 (61865) 12040 (63255)
Median prescribed
volume ml xxxx xxxx 8000 11333 8000 11783
Most recent 4-hour
PET test result
for D/P creatinine
Range xxxx xxxx 0.28–1.04 0.28–1.05 0.27–1.02 0.25–1.04
Mean xxxx xxxx 0.675 (60.12) 0.668 (60.14) 0.674 (60.14) 0.667 (60.14)
Median xxxx xxxx 0.670 0.660 0.680 0.680
There was a low number of patients for 1995 cycler cohort. The percentage of cycler patients over the three-year study period increased as follows: 1995 5 25%;
1996 5 33%; 1997 5 43%.
The xxxx denotes data not collected during the 1995 study year.
reported; for the 1997 sample, 30% of this subgroup with attempt was made in 1997, compared with 1996, to im-
prove the dose of dialysis by providing a higher perito-calculated adequacy values were anuric, and 10% did
not have a renal component reported. Note that in both neal dose of dialysis.
Prescription information was collected only in 19961996 and 1997 the decline in the renal component of
dialysis adequacy as duration of dialysis increases is not and 1997. Although the most common CAPD prescrip-
tion was still four 2-liter exchanges per day, prescriptionmatched by an equivalent increase in the peritoneal com-
ponent of dialysis adequacy. In addition, there is a consis- patterns indicate an effort to improve CAPD adequacy
by increasing the exchange volume and the number oftent decline in the peritoneal component of dialysis ade-
quacy as BSA increases. Although the difference in the daily exchanges. The average prescribed volume per day
increased from 8552 ml in 1996 to 8976 ml in 1997 (P ,peritoneal component was not significantly different
from 1996 to 1997, it does appear that a more aggressive 0.001; Table 5). In the 1997 PD-CIP cohort, prescriptions
Frankenfield et al: Trends in PD indicators 2005
Fig. 5. Relationship between prescribed volume and
duration of dialysis by quartiles of body surface area
(BSA) for adult CAPD patients in 1997, ESRD Core
Indicators Project. Significant differences in the pre-
scribed volume by BSA quartile for all durations of
dialysis are P , 0.001.
Fig. 6. Relationship between prescribed volume and
duration of dialysis by quartiles of BSA for adult cycler
patients in 1997. ESRD Core Indicators Project. Signifi-
cant differences in prescribed volume by BSA quartile
for durations of dialysis are: ,1 year P , 0.001; for 1
to 2 years P , 0.05; for 21 years P , 0.01.
for 31% of CAPD patients were for exchange volumes between 120 and 149 minutes. Daytime dwell times were
uniformly distributed between 240 and 960 minutes.of 2500 ml or more, and prescriptions for 22% of patients
specified more than four daily exchanges. Sixty-two percent of cycler patients were prescribed at
least one daytime dwell. The average prescribed volumeThe prescription patterns for the cycler cohort were
more varied. In the 1997 PD-CIP cohort, for nighttime per day increased from 11,803 ml in 1996 to 12,040 ml
in 1997 (P 5 NS).dwell volumes, 40% of patients had 2000 ml dwell vol-
umes; 23% had 2500 ml volumes, and 16% had dwell Figures 5 and 6 depict the relationship between total
prescribed volume and both duration of dialysis (a surro-volumes between 2000 and 2500 ml. On average, daytime
dwell volumes were lower than nighttime dwell volumes. gate for residual renal function) and BSA. For the CAPD
and cycler cohorts, the average prescription volume in-Most patients had a single nighttime dwell time between
60 and 150 minutes, with 29% of patients having a dwell creased significantly with longer duration of dialysis (P ,
0.001 and P , 0.01, respectively) and increasing BSAtime between 60 and 89 minutes, 34% with a dwell time
between 90 and 119 minutes, and 20% with a dwell time (P , 0.01 and P , 0.001, respectively).
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Table 6. Mean hematocrit values and the percent of patients who had hematocrit values meeting subsequently published DOQI guidelinesa,
by gender, race, age group, primary diagnosis, and modality, 1995–1997; ESRD Core Indicators Project
1996 1997
1995 CAPD CAPD Cycler patients CAPD Cycler patients
Mean % meeting Mean % meeting Mean % meeting Mean % meeting Mean % meeting
% DOQI % DOQI % DOQI % DOQI % DOQI
Total 32.48 30 33.14 34 33.17 37 33.89 40 33.67 40
Gender
Males 33.14d 32 33.87d 35 33.88d 38 34.46d 39 34.19c 40
Females 31.75 27 32.29 33 32.22 34 33.31 40 33.06 41
Race
African American 30.93d 20 32.51b 26 31.74c 30 33.02c 39 32.40c 37
Caucasian 33.07 34 33.45 36 33.66 38 34.31 39 34.08 41
Other/unknown 32.42 27 32.99 41 33.17 45 33.58 47 33.44 50
Age group years
18–44 31.71c 25 32.60 26 32.23b 30 33.41 38 32.51c 34
45–64 32.54 30 33.21 34 33.40 36 33.85 39 34.07 40
651 33.08 35 33.51 40 33.74 44 34.40 43 34.12 48
Primary diagnosis
Diabetes mellitus 32.34 28 33.08 36 33.05 29 33.91 42 33.72 43
Hypertension 32.20 29 32.81 32 32.58 47 33.60 40 33.78 41
Glomerulonephritis 32.81 30 33.13 35 33.55 42 33.79 42 33.37 38
Other/unknown 32.43 29 33.55 32 33.54 33 34.17 35 33.69 38
a DOQI guidelines: target range for hematocrit values 5 33%–36%
Statistically significant differences in patient characteristic group means denoted by: b P , 0.05; c P , 0.01; d P , 0.001
From a theoretical standpoint, patients with high peri-
toneal membrane characteristics would more likely ben-
efit from the short dwell times provided by cycler ther-
apy, whereas patients with low or low-average transport
characteristics would more likely benefit from the longer
dwell times provided by CAPD. There was not, however,
any significant difference in mean peritoneal transport
characteristics, as measured by the four-hour dialysis
to plasma ratio for creatinine (D/P Cr) values between
CAPD patients and cycler patients.
Management of anemia
Fig. 7. Percentage of peritoneal dialysis patients with mean hematocrit
For CAPD patients, the mean hematocrit value in- values between 33 to 36%, by modality from 1995 to 1997, ESRD
Core Indicators Project. Symbols are: ( ) CAPD patients; ( ) cyclers.creased from 32.5% in 1995 to 33.9% in 1997 (P , 0.001).
Significant difference in the percent of patients with hematocrit 33-For cycler patients, it increased from 33.2% in 1996 to
36%, 1995-1997 for CAPD patients is P , 0.001. There was no significant
33.7% in 1997 (NS; Table 6) There were significant dif- difference in the percent of patients with hematocrit 33–36% 1996–1997
for cycler patients.ferences in mean hematocrit values and in the percent-
ages of patients with hematocrit values within the subse-
quently published DOQI’s Clinical Practice Guidelines
for the Treatment of Anemia of Chronic Renal Failure than 44 years of age had a significantly higher risk of
(guideline number 4) [13] target range of 33 to 36% severe anemia than did Caucasians and older patients,
by patient characteristics (Table 6). Generally, females, respectively (data not shown). There was no significant
African Americans, and younger patients (18 to 44 years) difference in the proportion of patients with severe ane-
exhibited significantly lower hematocrit values compared mia by PD modality.
with males, Caucasians, and older patients. The improve- The mean weekly epoetin alfa dose increased for
ment in the percentage of patients having hematocrit CAPD patients from 114.3 units/kg/week in 1995 to 129.1
values within the DOQI target range of 33 to 36% over units/kg/week in 1997 (P , 0.001). Similarly, the mean
the study period is depicted in Figure 7 (P , 0.001). The weekly epoetin alfa dose for cycler patients increased
prevalence of severe anemia (defined as a hematocrit of from 122.0 units/kg/week in 1996 to 139.1 units/kg/week
less than 25%) improved from 6% in 1995 to 1.4% in in 1997 (P , 0.001). For the 1997 cohort, epoetin alfa
was used in 94% of patients when the hematocrit values1997 (P , 0.001). African Americans and adults less
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Table 7. Serum albumin and blood pressures values in U.S. adult (aged $ 18 years) peritoneal dialysis patients from 1995 to 1997;
ESRD Core Indicators Project
1995 1996 1997
CAPD Cycler patientsa CAPD Cycler patients CAPD Cycler patients
Albumin data
Mean serum albumin g/dl (BCG) 3.46 (60.50) 3.39 (60.51) 3.53 (60.59) 3.51 (60.51) 3.49 (60.48) 3.52 (60.46)
Median serum albumin g/dl (BCG) 3.5 3.4 3.6 3.6 3.5 3.6
Mean serum albumin g/dl (BCP) 3.18 (60.61) 2.94 (60.54) 3.16 (60.61) 3.28 (60.51) 3.29 (60.49) 3.32 (60.55)
Median serum albumin g/dl (BCP) 3.3 3.0 3.2 3.4 3.3 3.4
N (%) patients with serum albumin
,3.2 (BCP)/3.5 (BCG) g/dl 442 (48) 39 (53) 348 (44) 156 (40) 335 (45) 221 (43)
Blood pressure data
Mean systolic BP (mm Hg) 138.6 (622.0) 141.8 (623.1) 138.4 (620.3) 136.7 (619.8) 137.8 (621.5) 137.3 (620.5)
Median systolic BP (mm Hg) 137 140 138 137 138 137
Mean diastolic BP (mm Hg) 80.3 (612.0) 83.0 (612.6) 80.0 (611.8) 79.4 (611.1) 79.8 (612.0) 80.0 (611.2)
Median diastolic BP (mm Hg) 80 84 80 79 80 80
N (%) patients with HTNb 328 (34) 34 (11) 270 (34) 125 (31) 254 (34) 163 (32)
a Low number of patients for 1995 cycler cohort
b HTN defined as either systolic BP . 150 mm Hg or diastolic BP . 90 mm Hg
Abbreviations are: BCG, bromcresol green; BCP, bromcresol purple laboratory methods.
Fig. 8. Percentage of adult peritoneal dialysis
patients with blood pressure values within
JNC6 categories, 1995 to 1997, ESRD Core
Indicators Project. Abbreviation HTN is hy-
pertension. Symbols are: (r, dashed line)
1995; (n, thin line) 1996; ( , heavy line) 1997.
were less than 31%, in 93% of patients when the hemato- than those determined by the BCG method; these results
are consistent with those of other investigators [14]. Forcrit was between 31 and 35%, and in 59% of patients
when the hematocrit was 36% or more. the 1997 cohort, a lower serum albumin level was more
likely in women versus men (P , 0.001), African Ameri-
Serum albumin cans versus Caucasians (P , 0.05), patients greater than
65 years of age versus younger patients (P , 0.001),The mean serum albumin value for patients in the
1997 PD-CIP cohort was 3.5 g/dl by the BCG method and patients with diabetes as the primary cause of their
ESRD versus patients with ESRD from other causes(952 patients) and was 3.3 g/dl by the BCP method (203
patients). There has been little improvement in serum (P , 0.001). There was no significant difference in the
proportion of patients with low serum albumin levels byalbumin values over the three-year study period (Table
7). Approximately one half of the adult PD patients PD modality.
had serum albumin levels below 3.5 g/dl (by the BCG
Blood pressure controllaboratory method) or 3.2 g/dl (by the BCP laboratory
method). As expected, the mean serum albumins deter- There has been little improvement in the distribution
of blood pressure values by JNC6 category [15] or themined by the BCP method were systematically lower
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percentage of adult PD patients with hypertension (de- nal function, and that prescriptions are increased as the
glomerular filtration rate falls. The new DOQI guidelinesfined for this report as systolic blood pressure of more
than 150 mm Hg or diastolic blood pressure of more are now recommending measuring residual renal func-
tion at least twice in the first six months of dialysis andthan 90 mm Hg; Fig. 8 and Table 7) Approximately one
third of patients each study year had hypertension. In every four months thereafter until the weekly renal Kt/V
urea falls to less than 0.1 [12].the 1997 PD-CIP cohort, patients at increased risk of
hypertension included males (vs. females, P , 0.05) and Two groups, males and African Americans, had lower
adequacy values compared with other gender and raceAfrican Americans (vs. other racial groups, P , 0.05).
There was no significant difference in the proportion of groups. These lower adequacy values were most likely
secondary to the higher values of V and BSA in thesepatients with hypertension by PD modality.
patient subgroups. Although there was a trend to pre-
scribe more dialysis as BSA increased, the infused higher
DISCUSSION
volume did not compensate for larger size.
The ESRD CIP is designed to collect clinical informa- The choice of PD modality does not seem to be influ-
tion annually on a national sample of adult hemodialysis enced by peritoneal membrane characteristics as the av-
and PD patients from which comparative information is erage PET D/P ratios are similar for cycler and CAPD
fed back to dialysis providers in the form of national patients. Cycler dialysis has been recommended for pa-
and regional profiles to assist them in improving care tients with high transport rates and may be contraindi-
for their patients. This intervention approach is in keep- cated for patients with very low transport rates [17].
ing with the initiatives of other health care quality organi- Keshaviah notes that cycler therapy may not be appro-
zations such as the Joint Commission for Accreditation priate for patients with low transport characteristics be-
of Health Care Organizations (JCAHO) and the Health cause of the short duration of nighttime exchanges [18].
Plan Employer Data and Information Set (HEDIS), in Furthermore, increasing the number of exchanges does
which measurement systems are being used to support not improve small solute clearances because this short-
quality review activities associated with accreditation ens dwell times. Therefore, in a subset of patients on
[16]. The database established by the ESRD CIP allows cycler therapy who have low to low average transport
providers of ESRD services, over time, to benchmark rates, the use of cycler therapy contributes to the diffi-
their performance by comparing their patients’ values culty of achieving an adequate dose of dialysis.
to national and regional profiles, to set new target ranges, Patients with a duration of dialysis greater than two
and to identify opportunities to improve continuously years and patients in the highest quartile of BSA were
their processes of care and patient outcomes. Even found to have an increased risk of receiving dialysis that
though the data collected through the ESRD CIP are 6 would not have met subsequently published DOQI ade-
to 12 months old when distributed to all providers in quacy guidelines. An analysis of the peritoneal clear-
the United States, they are the most current source of ances by these two variables suggests that the dialysis
national (hemodialysis and PD) and regional (hemodial- prescription may not be adequately modified to compen-
ysis) comparative data on adult dialysis patients. sate for these variables. Dialysis prescriptions can be
Although there have been incremental increases in quantitatively increased by increasing the daily dialysate
both the mean weekly Kt/V urea and weekly creatinine drainage volume and maximizing dwell times [18–20].
clearance over the past three years, in 1997, only 36% Increasing the dialysate volume can be accomplished by
of CAPD and cycler patients with and without a daytime an increased use of 2.5 or 3.0 liter fill volumes or an
dwell met the subsequently published DOQI guidelines’ increase in the number of exchanges. A daytime dwell
recommendation for a weekly Kt/V urea of $2.0, 2.1, may be added for overnight cycler patients, or an addi-
and 2.2, respectively. Thirty-four percent of CAPD and tional nighttime exchange using an automated exchange
33% of cycler patients with and without a daytime dwell device may be added for CAPD patients. Blake et al
achieved the recommended weekly creatinine clearance believe that with the exception of high transporters, all
of 60, 63, and 66 liter/week/1.73 m2, respectively. cycler patients will require a daytime exchange(s) in the
As time on dialysis increased, the adequacy values absence of residual renal function [19]. Whereas increas-
progressively decreased. Although there was an increase ing the number of exchanges will improve adequacy in
in prescription volume with duration of dialysis, the loss patients with high peritoneal transport rates, patients
of renal function was not offset by a corresponding in- with low peritoneal transport may benefit most from an
crease in the dialysis prescription sufficient to result in increased exchange volume and a more even distribution
adequate dialysis according to subsequently published of dwell times [18–20].
DOQI guidelines. It is critical that residual renal function There has been a significant improvement in overall
is monitored closely during the early months of dialysis anemia management over the last three years. For
CAPD patients, the mean hematocrit improved fromtherapy, that prescriptions anticipate gradual loss of re-
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32.5 to 33.9%, with the percentage of patients who meet ancy remain unclear, but may also be related to ade-
quacy, nutritional status, or iron availability or stores.the subsequently published DOQI guidelines (target
The improvements in anemia management occurredrange of 33 to 36%) increasing from 30 to 40%. The
with a concomitant increase in the doses of epoetin alfa.respective data for cycler patients, which was collected
For CAPD, the mean dose increased from 114.3 to 129for the last two years only, also showed an improvement,
units/kg/week. For cycler patients, the dose increasedalbeit less marked. The mean cycler hematocrit increased
from 122 to 139.1 units/kg/week. The iron status of thesefrom 33.2 to 33.7%, with the percentage meeting the
patients is unknown, but it might be speculated that thesubsequently published DOQI guidelines increasing
method of delivery of iron may have changed substan-from 37 to 40% of patients. It is unclear why there is
tially from predominantly oral supplementation in 1995such a disparity in the improvements between CAPD
to an increase in the use of parenteral iron by 1997, asand cycler patients. It is unlikely that the differences
has been suggested by the subsequently published DOQIrepresent a function of dialysis adequacy because the
guidelines.mean Kt/V and weekly creatinine clearances of CAPD
Little improvement has been noted over this time pe-and cycler patients are similar. In addition, there are no
riod in proportion of patients with serum albumin levelssignificant differences in the groups’ nutritional status, as
of more than or equal to 3.5 or 3.2 g/dl (BCG or BCPmeasured by serum albumin concentrations, suggesting
laboratory method, respectively) or in the proportion ofthat this is not a reason for differences in hematocrit.
patients with hypertension. There was also no significantRegardless, there is still substantial room for improve-
change in serum albumin levels over a three-year periodment in all patients’ anemia management.
in hemodialysis patients, despite a statistically significantOf interest is the marked improvement in the anemia
increase in dialysis dose.management of female patients, both CAPD and cycler.
The HCQIP not only involves the collection and distri-In 1995, 32% of male and 27% of female CAPD patients
bution of clinical comparative data, as provided throughmet the subsequently published DOQI guidelines. By
the ESRD CIP, it also includes focused facility-specific1997, these had changed to 39 and 40%, respectively.
intervention activities conducted by the 18 ESRD net-Female cycler patients also demonstrated a similar dra-
works nationwide. These focused, facility-specific inter-matic improvement over the last two years.
vention strategies include educational workshops ex-Of continuing concern is the fact that, in general, ane-
plaining CQI techniques and the use of comparative datamia management in African American patients is infe-
to initiate process improvement at the facility level. Fromrior to that of Caucasian patients. This has been ad-
July 1994 to June 1997, network-specific interventiondressed in CAPD patients to a greater extent than in
activities primarily targeted the areas of adequacy of
cycler patients. In 1995, only 20% of African American
hemodialysis and anemia management. During the time
CAPD patients attained the target range of 33 to 36% period of October 1993 to April 1997 (the time frame
hematocrit, compared with 34% of Caucasians. In 1997, covered by the ESRD CIP), the ESRD CIP, as well as
the percentage of patients reaching this target had in- studies conducted by the U.S. Renal Data System, have
creased to 39% for both groups, although the mean he- reported improvement in the percentage of patients
matocrits were 33.0 and 34.3% for African Americans achieving higher levels of adequacy of dialysis and higher
and Caucasians, respectively. This would suggest that hematocrit levels in both the hemodialysis population
the data for African Americans are skewed to some and the PD population.
extent, with a larger number of these patients having Intervention or quality improvement activities to assist
low hematocrits. Of interest, the differences are more providers to improve care and patient outcomes are con-
marked for cycler patients, and it is tempting to speculate tinuing in the ESRD networks. Currently, five regional
that the lower adequacy of PD for cycler African Ameri- networks are working with providers in their area to
cans versus Caucasians (weekly creatinine clearance 64.0 improve the number of patients receiving adequate PD.
and 68.7 liter/week/1.73 m2, respectively) may be contrib- These projects are designed with preintervention and
utory. postintervention measurement phases, as well as an eval-
There continues to be a significant difference in the uation component so that the effectiveness of the inter-
mean hematocrits and the percentage of patients who vention technique(s) used in the project can be de-
would have met the subsequently published DOQI scribed. Over the next few years, we envision that
guidelines between younger versus older patients. For additional networks will be reporting their experience
CAPD, the mean hematocrit remains a full 1% higher in helping providers improve care and outcomes for PD
for older (more than 65 years) patients compared with patients.
younger (18 to 44 years) patients, and 14% more older Although there has been an increase in the proportion
cycler patients reached the target hematocrit range com- of patients with at least one adequacy measure in each
of the three six-month time periods during the 1995 topared with younger patients. The reasons for this discrep-
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